Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew P McGovern

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Leukemia & Lymphoma|June 8, 2013
DNMT3A mutations at R882 hotspot are only found in major clones of acute myeloid leukemiaKathrin E Bisling, John N Brewin, Andrew P McGovern, et al.
Diabetologia|June 5, 2023
HbAKatherine G Young, Andrew P McGovern, Inês Barroso, et al.
Diabetes Care|October 24, 2020
Type 2 Diabetes and COVID-19-Related Mortality in the Critical Care Setting: A National Cohort Study in England, March-July 2020John M Dennis, Bilal A Mateen, Raphael Sonabend, et al.
BMJ Open Diabetes Research & Care|May 26, 2020
Risk factors for genital infections in people initiating SGLT2 inhibitors and their impact on discontinuationAndrew P McGovern, Michael Hogg, Beverley M Shields, et al.
BMC Nephrology|September 20, 2013
Association of chronic kidney disease (CKD) and failure to monitor renal function with adverse outcomes in people with diabetes: a primary care cohort studyAndrew P McGovern, Benjamin Rusholme, Simon Jones, et al.
Diabetes Care|September 2, 2017
Incidence, Demographics, and Clinical Characteristics of Diabetes of the Exocrine Pancreas (Type 3c): A Retrospective Cohort StudyChris Woodmansey, Andrew P McGovern, Katherine A McCullough, et al.
Diabetes, Obesity & Metabolism|March 5, 2019
Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: A retrospective analysis of primary care data, 2010-2017John M Dennis, William E Henley, Andrew P McGovern, et al.
BMJ Open|January 31, 2024
Risk factor associations for severe COVID-19, influenza and pneumonia in people with diabetes to inform future pandemic preparations: UK population-based cohort studyRhian Hopkins, Katherine G Young, Nicholas J Thomas, et al.
Diabetologia|November 9, 2025
Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protectionThijs T Jansz, Katherine G Young, Rhian Hopkins, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 28, 2022
Patient-led rapid titration of basal insulin in gestational diabetes is associated with improved glycaemic control and lower birthweightAndrew P McGovern, Kagabo D Hirwa, Abigail K Wong, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Leukemia & Lymphoma|June 8, 2013
DNMT3A mutations at R882 hotspot are only found in major clones of acute myeloid leukemiaKathrin E Bisling, John N Brewin, Andrew P McGovern, et al.
Diabetologia|June 5, 2023
HbAKatherine G Young, Andrew P McGovern, Inês Barroso, et al.
Diabetes Care|October 24, 2020
Type 2 Diabetes and COVID-19-Related Mortality in the Critical Care Setting: A National Cohort Study in England, March-July 2020John M Dennis, Bilal A Mateen, Raphael Sonabend, et al.
BMJ Open Diabetes Research & Care|May 26, 2020
Risk factors for genital infections in people initiating SGLT2 inhibitors and their impact on discontinuationAndrew P McGovern, Michael Hogg, Beverley M Shields, et al.
BMC Nephrology|September 20, 2013
Association of chronic kidney disease (CKD) and failure to monitor renal function with adverse outcomes in people with diabetes: a primary care cohort studyAndrew P McGovern, Benjamin Rusholme, Simon Jones, et al.
Diabetes Care|September 2, 2017
Incidence, Demographics, and Clinical Characteristics of Diabetes of the Exocrine Pancreas (Type 3c): A Retrospective Cohort StudyChris Woodmansey, Andrew P McGovern, Katherine A McCullough, et al.
Diabetes, Obesity & Metabolism|March 5, 2019
Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: A retrospective analysis of primary care data, 2010-2017John M Dennis, William E Henley, Andrew P McGovern, et al.
BMJ Open|January 31, 2024
Risk factor associations for severe COVID-19, influenza and pneumonia in people with diabetes to inform future pandemic preparations: UK population-based cohort studyRhian Hopkins, Katherine G Young, Nicholas J Thomas, et al.
Diabetologia|November 9, 2025
Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protectionThijs T Jansz, Katherine G Young, Rhian Hopkins, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 28, 2022
Patient-led rapid titration of basal insulin in gestational diabetes is associated with improved glycaemic control and lower birthweightAndrew P McGovern, Kagabo D Hirwa, Abigail K Wong, et al.
Pageof 4